Inventor
SLEEMAN MARK
AU10 patents
⚠️ This page may combine multiple inventors who share the name “SLEEMAN MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
7 patentsUS9587029B2Mar 7, 2017
Human antibodies to the glucagon receptor and methods of use thereof
REGENERON PHARMA15 citations91
US9127068B2Sep 8, 2015
Nucleic acids encoding human glucagon receptor antibodies
REGENERON PHARMA20 citations91
US10233250B2Mar 19, 2019
Human antibodies to the glucagon receptor and methods of use thereof for lowering blood glucose or ketone levels
REGENERON PHARMA4 citations82
US12269889B2Apr 8, 2025
Human antibodies to the human glucagon receptor (HGCGR) and methods of use thereof to lower blood glucose or ketone levels
REGENERON PHARMA0 citations61
US11498970B2Nov 15, 2022
Human antibodies to the human glucagon receptor and methods of use thereof to lower blood glucose or ketone levels
REGENERON PHARMA0 citations61
US12250931B2Mar 18, 2025
Genetically modified mouse with a humanized PNPLA3 gene and methods of use
REGENERON PHARMA0 citations60
US10640566B2May 5, 2020
Nucleic acid molecules encoding antibodies to the human glucagon receptor
REGENERON PHARMA0 citations51